Michael Mason Karyopharm Therapeutics Inc. (KPTI) insider trading activity

Michael Mason is EVP, CFO & Treasurer of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 391,054 shares of KPTI, which is worth approximately $250,274. The most recent transaction as insider was on Sep 04, 2024, when has been sold 7,050 shares (Common Stock) at a price of $0.72 per share, resulting in proceeds of $5,076. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 391K

0% 3M change

64.43% 12M change

Total Value Held $250,274

Michael Mason Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 04 2024	SELL Open market or private sale	$5,076 $0.72 p/Share	7,050 Reduced 1.77%	391,054 Common Stock
Jun 04 2024	SELL Open market or private sale	$645 $0.99 p/Share	652 Reduced 0.16%	398,104 Common Stock
Mar 01 2024	SELL Open market or private sale	$7,394 $1.2 p/Share	6,162 Reduced 1.52%	398,756 Common
Feb 29 2024	SELL Open market or private sale	$32,393 $1.17 p/Share	27,687 Reduced 6.4%	404,918 Common
Feb 28 2024	BUY Grant, award, or other acquisition	-	188,205 Added 30.32%	432,605 Common Stock
Feb 27 2024	SELL Open market or private sale	$3,359 $1.32 p/Share	2,545 Reduced 1.03%	244,400 Common Stock
Feb 06 2024	SELL Open market or private sale	$6,685 $1.59 p/Share	4,205 Reduced 1.67%	246,945 Common Stock
Jan 24 2024	BUY Grant, award, or other acquisition	-	13,333 Added 5.04%	251,150 Common Stock
Sep 01 2023	SELL Open market or private sale	$9,194 $1.33 p/Share	6,913 Reduced 2.82%	237,817 Common Stock
Jun 02 2023	SELL Open market or private sale	$1,400 $2.22 p/Share	631 Reduced 0.26%	244,730 Common Stock
Mar 01 2023	SELL Open market or private sale	$33,951 $3.03 p/Share	11,205 Reduced 4.37%	245,361 Common Stock
Feb 28 2023	BUY Grant, award, or other acquisition	-	95,000 Added 27.02%	256,566 Common Stock
Feb 27 2023	SELL Open market or private sale	$8,518 $3.04 p/Share	2,802 Reduced 1.7%	161,566 Common Stock
Feb 06 2023	SELL Open market or private sale	$14,079 $3.4 p/Share	4,141 Reduced 2.46%	164,368 Common Stock
Aug 31 2022	BUY Grant, award, or other acquisition	-	30,000 Added 15.11%	168,509 Common Stock
Jun 03 2022	SELL Open market or private sale	$3,642 $6.06 p/Share	601 Reduced 0.43%	138,509 Common Stock
Feb 28 2022	SELL Open market or private sale	$24,556 $10.24 p/Share	2,398 Reduced 1.69%	139,110 Common Stock
Feb 28 2022	BUY Grant, award, or other acquisition	-	88,200 Added 38.4%	141,508 Common Stock
Feb 07 2022	SELL Open market or private sale	$38,917 $9.86 p/Share	3,947 Reduced 6.89%	53,308 Common Stock
Jun 01 2021	BUY Grant, award, or other acquisition	-	5,500 Added 8.76%	57,255 Common Stock
Feb 25 2021	BUY Grant, award, or other acquisition	-	22,013 Added 29.84%	51,755 Common Stock
Feb 11 2021	SELL Open market or private sale	$44,356 $15.52 p/Share	2,858 Reduced 35.07%	5,292 Common Stock
Feb 05 2021	BUY Exercise of conversion of derivative security	-	8,150 Added 50.0%	8,150 Common Stock

Michael Mason

EVP, CFO & Treasurer

Newton, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPTI shares.

Notify only if

Value

Insider Trading

Get notified when an Karyopharm Therapeutics Inc. insider buys or sells KPTI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Karyopharm Therapeutics Inc.

Track Activities on KPTI

Account